サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439666

吸収性止血剤 - 世界市場の考察、競合情勢、市場予測（2030年）

Absorbable Hemostats - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
吸収性止血剤 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の吸収性止血剤の市場規模は、予測期間（2024年～2030年）にCAGRで6.47％の成長が見込まれます。市場は、脊椎疾患の罹患率の上昇、手術中の患者の出血管理への注目の高まり、製品開発における技術革新などの要因によってプラス成長を示しており、2024年～2030年の予測期間における吸収性止血剤市場の成長に寄与しています。

吸収性止血剤の市場力学

吸収性止血剤市場はさまざまな理由によって製品需要が拡大しており、市場の成長に影響を与えている主な要因の1つは、脊椎疾患の罹患率の上昇です。

世界保健機関（WHO）によると、2020年に世界で約17億1,000万人が筋骨格系の疾患に苦しむ傾向にあります。

前述の資料によれば、2020年、筋骨格系疾患の中で腰痛がもっとも大きな負担を引き起こし、その有病者数は世界で5億6,800万人に上りました。

世界保健機関（WHO）（2022）によると、筋骨格系疾患は世界の身体障害の主な原因であり、腰痛は160ヶ国で身体障害の主な原因となっています。

さらに、交通事故や転倒などによる外傷の増加は、脊椎損傷を引き起こす可能性が高く、吸収性止血剤の需要をさらに増加させます。

世界保健機関（WHO）（2022）が発表したデータによると、毎年世界中で25万人～50万人が脊髄損傷（SCI）を負っており、脊髄損傷の大部分は交通事故、転倒、暴力によるものです。

また、Nogo Inhibition in Spinal Cord Injuryによると、2020年に、EUで年間約1万人が新たに脊髄損傷に罹患し、通常の平均寿命により、EUでは20万人以上の患者が脊髄損傷とともに生活しています。

それゆえ、上記の要因からスポーツ傷害や脊髄疾患の早期回復を可能にする吸収性止血剤のニーズが世界的に高まっており、世界の吸収性止血剤市場の全体的な成長につながっています。

したがって、上記のすべての要因から今後数年間の吸収性止血剤の拡大が予測され、2024年～2030年の予測期間における吸収性止血剤市場の成長に寄与しています。

しかし、吸収性止血剤の効果的な使用に熟練した専門家の不足や、吸収性止血剤の高いコストは、吸収性止血剤市場の成長の一定の抑制要因となる可能性があります。

前例のないCOVID-19の発生は、吸収性止血剤市場に大きな影響を与えました。COVID-19パンデミック中、ロックダウン規制が敷かれたため、患者の受診が減少し、その他のすべての外科手術が一時的に中断され、COVID-19に罹患した患者により多くの注意が払われるようになっていました。しかし、さまざまなワクチンの発売により通常業務が再開され、パンデミック後の吸収性止血剤市場の成長につながっています。

吸収性止血剤市場のセグメント分析

吸収性止血剤市場の製剤化剤セグメントでは、マトリクス・ゲル止血剤が2024年～2030年の予測期間に吸収性止血剤市場で大きなシェアを占めると予測されます。これは、外科手術において創傷の輪郭に適合し、深い病変を埋めることができることによるものと考えられます。

マトリクスはより効果的な止血剤であることが証明されており、その他の止血剤と比較してより迅速な止血と良好な治療成績を示します。

さらに、マトリクス・ゲル止血剤の使用は、術後の合併症、再手術、輸血の減少、手術時間の短縮につながることも調査で示されています。

さらに、さまざまな形態のゼラチンの重要な特性は、血液や体液をその重量の40倍以上吸収する能力と、生体内で体積を200％膨張させる能力です。つまり、ゼラチン形態は、コラーゲンや再生酸化セルロースをベースとする局所止血剤よりも体積を増加させるということです。

それゆえ、マトリクス・ゲル止血剤はその他の製剤化剤と比較して優れています。したがって、前述のすべての要因が予測期間に吸収性止血剤市場におけるマトリクス・ゲルカテゴリの成長を促進する可能性が高いです。

当レポートでは、世界の吸収性止血剤市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 吸収性止血剤市場レポートのイントロダクション

第2章 吸収性止血剤市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 吸収性止血剤市場の主な要因の分析

  • 吸収性止血剤市場の促進要因
    • 脊椎疾患の罹患率の増加
    • 手術中の患者の出血管理に対する注目の高まり
    • 製品開発における技術革新
  • 吸収性止血剤市場の抑制要因と課題
    • 吸収性止血剤製品の効果的な使用に熟練した専門家の不足
    • 吸収性止血剤の高いコスト
  • 吸収性止血剤市場の機会
    • 生体外科用吸収性止血剤製品の人気の高まり
    • 新興市場をターゲットにした製品の発売

第5章 吸収性止血剤市場のポーターのファイブフォース分析

第6章 吸収性止血剤市場に対するCOVID-19の影響分析

第7章 吸収性止血剤の市場レイアウト

  • タイプ別
    • トロンビンベース止血剤
    • 酸化再生セルロースベース止血剤
    • ゼラチンベース止血剤
    • コラーゲンベース止血剤
    • その他
  • 製剤化剤別
    • マトリクス・ゲル止血剤
    • スポンジ止血剤
    • 粉末止血剤
  • 用途別
    • 脳神経手術
    • 整形外科手術
    • 一般外科手術
    • 再建手術
  • エンドユーザー別
    • 病院、診療所
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 吸収性止血剤市場：世界の企業シェア分析 - 主要3～5社

第9章 吸収性止血剤市場の企業と製品のプロファイル

  • B.Braun
  • Baxter
  • Johnson & Johnson
  • BD
  • Cura Medical
  • GELITA MEDICAL
  • Curasan AG
  • Meril Life Sciences
  • Zhonghui Shengxi
  • Beijing Datsing Bio-tech
  • Guizhou Jin Jiu Biotech
  • Beijing Taikesiman
  • Foryou Medical
  • Saikesaisi Holdings Group
  • Biotemed
  • Hangzhou Singclean Medical Products
  • Teleflex Incorporated
  • Hemostasis, LLC
  • Stryker
  • Samyang Holdings Corporation

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Absorbable Hemostats Market in Global (2021-2030)
  • Table 4: Absorbable Hemostats Market in Global by Type (2021-2030)
  • Table 5: Absorbable Hemostats Market in Global by Formulants (2021-2030)
  • Table 6: Absorbable Hemostats Market in Global by Application (2021-2030)
  • Table 7: Absorbable Hemostats Market in Global by End User (2021-2030)
  • Table 8: Absorbable Hemostats Market in Global by Geography (2021-2030)
  • Table 9: Absorbable Hemostats Market in North America (2021-2030)
  • Table 10: Absorbable Hemostats Market in North America by Type (2021-2030)
  • Table 11: Absorbable Hemostats Market in North America by Formulants (2021-2030)
  • Table 12: Absorbable Hemostats Market in North America by Application (2021-2030)
  • Table 13: Absorbable Hemostats Market in North America by End User (2021-2030)
  • Table 14: Absorbable Hemostats Market in North America by Country (2021-2030)
  • Table 15: Absorbable Hemostats Market in the US (2021-2030)
  • Table 16: Absorbable Hemostats Market in Canada (2021-2030)
  • Table 17: Absorbable Hemostats Market in Mexico (2021-2030)
  • Table 18: Absorbable Hemostats Market in Europe (2021-2030)
  • Table 19: Absorbable Hemostats Market in Europe by Type (2021-2030)
  • Table 20: Absorbable Hemostats Market in Europe by Formulants (2021-2030)
  • Table 21: Absorbable Hemostats Market in Europe by Application (2021-2030)
  • Table 22: Absorbable Hemostats Market in Europe by End User (2021-2030)
  • Table 23: Absorbable Hemostats Market in Europe by Country (2021-2030)
  • Table 24: Absorbable Hemostats Market in France (2021-2030)
  • Table 25: Absorbable Hemostats Market in Germany (2021-2030)
  • Table 26: Absorbable Hemostats Market in the United Kingdom (2021-2030)
  • Table 27: Absorbable Hemostats Market in Italy (2021-2030)
  • Table 28: Absorbable Hemostats Market in Spain (2021-2030)
  • Table 29: Absorbable Hemostats Market in Russia (2021-2030)
  • Table 30: Absorbable Hemostats Market in Rest of Europe (2021-2030)
  • Table 31: Absorbable Hemostats Market in APAC (2021-2030)
  • Table 32: Absorbable Hemostats Market in APAC by Type (2021-2030)
  • Table 33: Absorbable Hemostats Market in APAC by Formulants (2021-2030)
  • Table 34: Absorbable Hemostats Market in APAC by Application (2021-2030)
  • Table 35: Absorbable Hemostats Market in APAC by End User (2021-2030)
  • Table 36: Absorbable Hemostats Market in APAC by Country (2021-2030)
  • Table 37: Absorbable Hemostats Market in China (2021-2030)
  • Table 38: Absorbable Hemostats Market in Japan (2021-2030)
  • Table 39: Absorbable Hemostats Market in India (2021-2030)
  • Table 40: Absorbable Hemostats Market in Australia (2021-2030)
  • Table 41: Absorbable Hemostats Market in South Korea (2021-2030)
  • Table 42: Absorbable Hemostats Market in Rest of APAC (2021-2030)
  • Table 43: Absorbable Hemostats Market in Rest of World (2021-2030)
  • Table 44: Absorbable Hemostats Market in RoW by Type (2021-2030)
  • Table 45: Absorbable Hemostats Market in RoW by Formulants (2021-2030)
  • Table 46: Absorbable Hemostats Market in RoW by Application (2021-2030)
  • Table 47: Absorbable Hemostats Market in RoW by End User (2021-2030)
  • Table 48: Absorbable Hemostats Market in RoW by Region (2021-2030)
  • Table 49: Absorbable Hemostats Market in Middle East (2021-2030)
  • Table 50: Absorbable Hemostats Market in Africa (2021-2030)
  • Table 51: Absorbable Hemostats Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Absorbable Hemostats Market in Global (2021-2030)
  • Figure 4: Absorbable Hemostats Market in Global by Type (2021-2030)
  • Figure 5: Absorbable Hemostats Market in Global by Formulants (2021-2030)
  • Figure 6: Absorbable Hemostats Market in Global by Application (2021-2030)
  • Figure 7: Absorbable Hemostats Market in Global by End User (2021-2030)
  • Figure 8: Absorbable Hemostats Market in Global by Geography (2021-2030)
  • Figure 9: Absorbable Hemostats Market in North America (2021-2030)
  • Figure 10: Absorbable Hemostats Market in North America by Type (2021-2030)
  • Figure 11: Absorbable Hemostats Market in North America by Formulants (2021-2030)
  • Figure 12: Absorbable Hemostats Market in North America by Application (2021-2030)
  • Figure 13: Absorbable Hemostats Market in North America by End User (2021-2030)
  • Figure 14: Absorbable Hemostats Market in North America by Country (2021-2030)
  • Figure 15: Absorbable Hemostats Market in the US (2021-2030)
  • Figure 16: Absorbable Hemostats Market in Canada (2021-2030)
  • Figure 17: Absorbable Hemostats Market in Mexico (2021-2030)
  • Figure 18: Absorbable Hemostats Market in Europe (2021-2030)
  • Figure 19: Absorbable Hemostats Market in Europe by Type (2021-2030)
  • Figure 20: Absorbable Hemostats Market in Europe by Formulants (2021-2030)
  • Figure 21: Absorbable Hemostats Market in Europe by Application (2021-2030)
  • Figure 22: Absorbable Hemostats Market in Europe by End User (2021-2030)
  • Figure 23: Absorbable Hemostats Market in Europe by Country (2021-2030)
  • Figure 24: Absorbable Hemostats Market in France (2021-2030)
  • Figure 25: Absorbable Hemostats Market in Germany (2021-2030)
  • Figure 26: Absorbable Hemostats Market in the United Kingdom (2021-2030)
  • Figure 27: Absorbable Hemostats Market in Italy (2021-2030)
  • Figure 28: Absorbable Hemostats Market in Spain (2021-2030)
  • Figure 29: Absorbable Hemostats Market in Russia (2021-2030)
  • Figure 30: Absorbable Hemostats Market in Rest of Europe (2021-2030)
  • Figure 31: Absorbable Hemostats Market in APAC (2021-2030)
  • Figure 32: Absorbable Hemostats Market in APAC by Type (2021-2030)
  • Figure 33: Absorbable Hemostats Market in APAC by Formulants (2021-2030)
  • Figure 34: Absorbable Hemostats Market in APAC by Application (2021-2030)
  • Figure 35: Absorbable Hemostats Market in APAC by End User (2021-2030)
  • Figure 36: Absorbable Hemostats Market in APAC by Country (2021-2030)
  • Figure 37: Absorbable Hemostats Market in China (2021-2030)
  • Figure 38: Absorbable Hemostats Market in Japan (2021-2030)
  • Figure 39: Absorbable Hemostats Market in India (2021-2030)
  • Figure 40: Absorbable Hemostats Market in Australia (2021-2030)
  • Figure 41: Absorbable Hemostats Market in South Korea (2021-2030)
  • Figure 42: Absorbable Hemostats Market in Rest of APAC (2021-2030)
  • Figure 43: Absorbable Hemostats Market in Rest of World (2021-2030)
  • Figure 44: Absorbable Hemostats Market in RoW by Type (2021-2030)
  • Figure 45: Absorbable Hemostats Market in RoW by Formulants (2021-2030)
  • Figure 46: Absorbable Hemostats Market in RoW by Application (2021-2030)
  • Figure 47: Absorbable Hemostats Market in RoW by End User (2021-2030)
  • Figure 48: Absorbable Hemostats Market in RoW by Region (2021-2030)
  • Figure 49: Absorbable Hemostats Market in Middle East (2021-2030)
  • Figure 50: Absorbable Hemostats Market in Africa (2021-2030)
  • Figure 51: Absorbable Hemostats Market in South America (2021-2030)
  • Figure 52: Market Drivers
  • Figure 53: Market Barriers
  • Figure 54: Marker Opportunities
  • Figure 55: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0506

Absorbable Hemostats Market By Type (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Others), By Formulants (Matrix & Gel Hemostats, Sponge Hemostats, Powder Hemostats, Others), By Application (Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising incidence of spinal ailments and rapid technological developmental activities in product arena

Global absorbable hemostats market is expected to grow at a CAGR of 6.47% during the forecast period (2024-2030). The absorbable hemostats market is witnessing positive growth owing to the factors such as rising incidence of spinal ailments, rising focus on blood loss management in patients during surgeries, technological innovation in product development, thereby contributing to the growth of the Absorbable Hemostats market during the forecast period from 2024-2030.

Absorbable Hemostats Market Dynamics:

The Absorbable Hemostats market is witnessing a growth in product demand owing to various reasons, one of the major factors influencing the growth of the absorbable hemostats market is the rising incidence of spinal ailments.

According to the World Health Organization 2022, in 2020 approximately 1.71 billion people tend to suffer from musculoskeletal conditions worldwide.

Report Metrics

Details

Study Period

2021 to 2030

Base Year

2022

Forecast Period

2024 to 2030

CAGR

6.47%

Market Size

--

Key Companies

B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, and others

As per the aforementioned source, in the year 2020 among musculoskeletal disorders, lower back pain had caused the highest-burden with a prevalence of 568 million people worldwide.

According to the World Health Organization 2022, musculoskeletal conditions are a leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries.

Moreover, a rise in traumatic injuries due to road crashes falls, and others are likely to cause spine injuries which will further increase the demand for Absorbable Hemostats.

As per the data published by the World Health Organization 2022, every year between 250,000 and 500,000 people suffer a spinal cord injury (SCI) around the world and the majority of spinal cord injuries are due to road traffic crashes, falls, or violence.

Additionally, the Nogo Inhibition in Spinal Cord Injury, in the year 2020, the incidence of spinal cord injury is about 10'000 newly injured people per year in the EU, and due to a normal life expectancy, more than 200,000 patients are living with a spinal cord injury in the EU.

Therefore, owing to the abovementioned factors, there is a growing need for absorbable hemostats in the market globally which allows faster recovery of sports-related injuries and spinal ailments, thereby leading to the overall growth of the global absorbable hemostats market.

Hence, all the above-mentioned factors are projected to augment for Absorbable Hemostats in the forthcoming years, thereby contributing to the growth of the Absorbable Hemostats market during the forecast period from 2024-2030.

However, the dearth of skilled professionals for effective use of absorbable hemostat products and the high cost of the absorbable hemostats may be certain limiting factors of the Absorbable Hemostats market growth.

The unprecedented COVID-19 outbreak had a profound impact on the market for absorbable hemostats. Owing to the lockdown restrictions posed during the COVID-19 pandemic, there were reduced patient visits and all other surgical procedures were temporarily paused, giving more attention to the COVID-19 inflicted patient. However, the launch of various vaccines has resumed normal operations further leading to the growth of the Absorbable Hemostats market during the post-pandemic.

Absorbable Hemostats Market Segment Analysis:

Absorbable Hemostats Market By Type (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Others), By Formulants (Matrix & Gel Hemostats, Sponge Hemostats, Powder Hemostats, Others), By Application (Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Others), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Formulants segment of the Absorbable Hemostats market, the Matrix & Gel Hemostats are estimated to hold a significant share in the Absorbable Hemostats market during the forecast period from 2024-2030. This can be attributed to the fact that in surgery, they can conform to wound contours and fill deep lesions.

The matrix is proven to be a more effective hemostat, demonstrating faster hemostasis and better outcomes compared with other formulants of hemostatic agents.

Moreover, research also indicates that the use of Matrix & Gel Hemostats is associated with fewer post-surgical complications, surgical revisions, and blood transfusions, as well as shorter surgical times.

Furthermore, an important property of the different forms of gelatin is its ability to absorb more than 40 times its weight in blood and fluids and its ability to expand its volume by 200% in vivo. This means that gelatin forms increase their volume more than the topical hemostatics based on collagen and regenerated oxidized cellulose.

Therefore, the advantages associated with Matrix & Gel Hemostats compared to other formulants. Thus, all the aforementioned factors are likely to propel the matrix & gels category growth in the absorbable hemostats market during the forecast period.

North America is expected to dominate the overall Absorbable Hemostats Market:

Among all the regions, North America is expected to account for the largest share in the Global Absorbable Hemostats market. The growing number of spine-related disorders among others will also increase the absorbable hemostats market in the United States.

Further, the rising adoption of Absorbable Hemostats in the country would result in the rising demand for treatments that make use of Absorbable Hemostats, which in turn would provide a conducive growth environment for the United States Absorbable Hemostats market as well as the North American region.

For instance, the National Spinal Cord Injury Statistical Center 2019, the United States population size of 328 million people worldwide. Also, the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million people in the United States, or about 17,730 new SCI cases each year.

Furthermore, according to the Miami Project 2020, in the year 2020, approximately 17,810 new spinal cord injuries each year in the US. Also, as per the aforementioned source, males account for about 78% of the new spinal cord injuries cases.

A rising focus on blood loss management in patients during surgeries will lead to an increase in the demand for absorbable hemostats, thereby leading to traction in the overall absorbable hemostats market.

Moreover, product approvals pertaining to absorbable hemostats will also lead to an increase in the demand for absorbable hemostats, thereby leading to an overall increase in the absorbable hemostat market.

For instance, on February 23, 2022, FDA had approved EndoClot® Hemostat to Manage GI Bleeding. EndoClot® PHS is a single-use device including a starch-based powder hemostat that is applied directly to the bleeding site through a flexible endoscope.

Thus, the interplay of all the aforementioned factors is likely to fuel the market growth of absorbable hemostats in the United States during the forecast period.

Furthermore, the increased emphasis on product development activities and the high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Absorbable Hemostats. Also, advanced product launches and commercialization agreements among the key companies are further expected to fuel the market.

Thus, the interplay of all the aforementioned factors is likely to fuel the regional market for Absorbable Hemostats during the forecasted period.

Absorbable Hemostats Market Key Players:

Some of the key market players operating in the Absorbable Hemostats market include B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products, Teleflex Incorporated, Hemostasis, LLC, Stryker, Samyang Holdings Corporation, and others.

Recent Developmental Activities in the Absorbable Hemostats Market:

On March 25, 2020, Ethicon, part of the Johnson & Johnson Medical Devices Companies, announced the strategic regional launch of SURGICEL® POWDER ABSORBABLE HEMOSTAT in Australia, New Zealand, and Thailand.

On January 09, 2018, Ethicon announced the US launch of SURGICEL® POWDER ABSORBABLE HEMOSTAT, a powdered adjunctive hemostat that was designed to help surgeons control disruptive bleeding more efficiently.

Key Takeaways from the Absorbable Hemostats Market Report Study

Market size analysis for current Absorbable Hemostats market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Absorbable Hemostats market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global Absorbable Hemostats market.

Various opportunities available for the other competitor in the Absorbable Hemostats market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current Absorbable Hemostats market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Absorbable Hemostats market growth in the coming future?

Target Audience who can be benefited from this Absorbable Hemostats Market Report Study

Absorbable Hemostats products providers

Research organizations and consulting companies

Absorbable Hemostats-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Absorbable Hemostats

Various End-users who want to know more about the Absorbable Hemostats market and latest technological developments in the Absorbable Hemostats market.

Frequently Asked Questions for Absorbable Hemostats Market:

1. What are Absorbable Hemostats?

Absorbable Hemostats are used adjunctively in surgical procedures to assist in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective.

2. What is the market for Global Absorbable Hemostats?

Global absorbable hemostats market is expected to grow at a CAGR of 6.47% during the forecast period (2024-2030).

3. What are the drivers for Global Absorbable Hemostats Market?

The Absorbable Hemostats market is witnessing a positive market growth owing to the factors such as rising incidence of spinal ailments, rising focus on blood loss management in patients during surgeries, technological innovation in product development.

4. Who are the key players operating in the Global Absorbable Hemostats Market?

Some of the key market players operating in the Absorbable Hemostats market include B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products, Teleflex Incorporated, Hemostasis, LLC, Stryker, Samyang Holdings Corporation and others.

5. Which region has the highest share in Absorbable Hemostats Market?

North America is expected to hold the highest share in the revenue in the Absorbable Hemostats market during the forecast period. The growing number of sports-related injuries and the rising number of spine-related disorders among others will also increase the absorbable hemostats market. Further, the rising adoption of Absorbable Hemostats in the country would result in the rising demand for treatments that make use of Absorbable Hemostats, which in turn would provide a conducive growth environment for the United States Absorbable Hemostats market as well as the North American region.

Table of Contents

1.Absorbable Hemostats Market Report Introduction

2.Absorbable Hemostats Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Absorbable Hemostats Market Key Factors Analysis

  • 4.1. Absorbable Hemostats Market Drivers
    • 4.1.1. Rising Incidence of Spinal Ailments
    • 4.1.2. Rising Focus on Blood Loss Management in Patients During Surgeries
    • 4.1.3. Technological Innovation in Product Development
  • 4.2. Absorbable Hemostats Market Restraints and Challenges
    • 4.2.1. The dearth of Skilled Professionals for Effective Use of Absorbable Hemostat Products
    • 4.2.2. High Cost of the Absorbable Hemostats
  • 4.3. Absorbable Hemostats Market Opportunities
    • 4.3.1. Rising Popularity of Biosurgical Absorbable Hemostat Product
    • 4.3.2. Targeting Emerging Markets for Product Launches

5. Absorbable Hemostats Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Absorbable Hemostats Market

7. Absorbable Hemostats Market Layout

  • 7.1. By Type
    • 7.1.1. Thrombin-Based Hemostats
    • 7.1.2. Oxidized Regenerated Cellulose-Based Hemostats
    • 7.1.3. Gelatin-Based Hemostats
    • 7.1.4. Collagen-Based Hemostats
    • 7.1.5. Others
  • 7.2. By Formulants
    • 7.2.1. Matrix & Gel Hemostats
    • 7.2.2. Sponge Hemostats
    • 7.2.3. Powder Hemostats
    • 7.2.4. Others
  • 7.3. By Application
    • 7.3.1. Neurosurgery
    • 7.3.2. Orthopedic Surgery
    • 7.3.3. General Surgery
    • 7.3.4. Reconstructive Surgery
    • 7.3.5. Others
  • 7.4. By End User
    • 7.4.1. Hospitals and Clinics
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. North America Absorbable Hemostats Market, by Type
      • 7.5.1.2. North America Absorbable Hemostats Market, by Formulants
      • 7.5.1.3. North America Absorbable Hemostats Market, by Application
      • 7.5.1.4. North America Absorbable Hemostats Market, by End User
      • 7.5.1.5. North America Absorbable Hemostats Market, by Country
      • 7.5.1.5.1. United States
      • 7.5.1.5.2. Canada
      • 7.5.1.5.3. Mexico
    • 7.5.2. Europe
      • 7.5.2.1. Europe Absorbable Hemostats Market, by Type
      • 7.5.2.2. Europe Absorbable Hemostats Market, by Formulants
      • 7.5.2.3. Europe Absorbable Hemostats Market, by Application
      • 7.5.2.4. Europe Absorbable Hemostats Market, by End User
      • 7.5.2.5. Europe Absorbable Hemostats Market, by Country
      • 7.5.2.5.1. France
      • 7.5.2.5.2. Germany
      • 7.5.2.5.3. United Kingdom
      • 7.5.2.5.4. Italy
      • 7.5.2.5.5. Spain
      • 7.5.2.5.6. Russia
      • 7.5.2.5.7. Rest of Europe
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. Asia-Pacific Absorbable Hemostats Market, by Type
      • 7.5.3.2. Asia-Pacific Absorbable Hemostats Market, by Formulants
      • 7.5.3.3. Asia-Pacific Absorbable Hemostats Market, by Application
      • 7.5.3.4. Asia-Pacific Absorbable Hemostats Market, by End User
      • 7.5.3.5. Asia-Pacific Absorbable Hemostats Market, by Country
      • 7.5.3.5.1. China
      • 7.5.3.5.2. Japan
      • 7.5.3.5.3. India
      • 7.5.3.5.4. Australia
      • 7.5.3.5.5. South Korea
      • 7.5.3.5.6. Rest of Asia Pacific
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. RoW Absorbable Hemostats Market, by Type
      • 7.5.4.2. RoW Absorbable Hemostats Market, by Formulants
      • 7.5.4.3. RoW Absorbable Hemostats Market, by Application
      • 7.5.4.4. RoW Absorbable Hemostats Market, by End User
      • 7.5.4.5. RoW Absorbable Hemostats Market, by Region
      • 7.5.4.5.1. Middle East
      • 7.5.4.5.2. Africa
      • 7.5.4.5.3. South America

8. Absorbable Hemostats Market Global Company Share Analysis - Key 3-5 Companies

9. Absorbable Hemostats Market Company and Product Profiles

  • 9.1. B.Braun
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Baxter
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Johnson & Johnson
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. BD
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Cura Medical
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. GELITA MEDICAL
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Curasan AG
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Meril Life Sciences
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Zhonghui Shengxi
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Beijing Datsing Bio-tech
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Guizhou Jin Jiu Biotech
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Beijing Taikesiman
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Foryou Medical
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Saikesaisi Holdings Group
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Biotemed
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Hangzhou Singclean Medical Products
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Teleflex Incorporated
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Hemostasis, LLC
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Stryker
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Samyang Holdings Corporation
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us